Motif Neurotech
TX - HoustonBiotechnology
Focus: Motif Neurotech is a Houston-based early-stage biotech developing the Motif XCS System, a wireless brain implant for treatment-resistant depression. The company operates at pre-clinical/early clinical scale with fewer than 50 employees.
Profile data last refreshed 39m ago · AI intelligence enriched 3w ago
Employees
1-50
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at Motif Neurotech?
AI assessmentHigh-risk, high-reward opportunity best suited to risk-tolerant early-career scientists or specialists seeking equity upside and deep involvement in a novel neurotech platform.
Why Work Here
- Ground-floor opportunity at a company with recent FDA clearance (April 2026) to initiate the first U.S. clinical trial of a wireless brain implant for treatment-resistant depression.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Motif XCS System
Major Depressive DisorderRecent News · Motif Neurotech(10)
Help build intelligence for Motif Neurotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.